Tarrant; James G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tarrant; James G..The latest application filed is for "cytochrome p450 inhibitors and uses thereof".

Company Profile

1.13.20

Tarrant; James G. - Lindenhurst NY
Tarrant; James G. - Searcy AR
Tarrant; James G. - Hamden CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cytochrome P450 Inhibitors And Uses Thereof App 20210171515 - Panicker; Bijoy ; et al.	2021-06-10
Cytochrome P450 inhibitors and uses thereof Grant 10,414,760 - Panicker , et al. Sept	2019-09-17
Cytochrome P450 Inhibitors And Uses Thereof App 20180148438 - Panicker; Bijoy ; et al.	2018-05-31
Cytochrome P450 Inhibitors And Uses Thereof App 20150158853 - Panicker; Bijoy ; et al.	2015-06-11
Small Molecule Anti-fibrotic Compounds And Uses Thereof App 20140329871 - Mishira; Rama K. ; et al.	2014-11-06
Cytochrome P450 inhibitors and uses thereof Grant 8,865,752 - Panicker , et al. October 21, 2	2014-10-21
Cytochrome P450 Inhibitors And Uses Thereof App 20140018401 - Panicker; Bijoy ; et al.	2014-01-16
Cytochrome P450 inhibitors and uses thereof Grant 8,513,291 - Panicker , et al. August 20, 2	2013-08-20
Cytochrome P450 Inhibitors And Uses Thereof App 20130102643 - Panicker; Bijoy ; et al.	2013-04-25
7-aminofuropyridine derivatives Grant 8,378,104 - Hornberger , et al. February 19, 2	2013-02-19
7-aminofuropyridine Derivatives App 20120046267 - Hornberger; Keith R. ; et al.	2012-02-23
Substituted 1-Benzyl-4-Substituted Piperazine Analogues App 20070249616 - Hutchison; Alan J. ; et al.	2007-10-25
Substituted 1-benzyl-4-substituted piperazine analogues Grant 7,253,168 - Hutchison , et al. August 7, 2	2007-08-07
Tyrosine kinase inhibitors Grant 7,223,757 - Wittman , et al. May 29, 2	2007-05-29
Tyrosine kinase inhibitors Grant 7,081,454 - Wittman , et al. July 25, 2	2006-07-25
Substituted 1-benzyl-4-substituted piperazine analogues App 20060142301 - Hutchison; Alan J. ; et al.	2006-06-29
Novel tyrosine kinase inhibitors App 20060079518 - Wittman; Mark D. ; et al.	2006-04-13
Aryl-substituted piperazine derivatives App 20060009456 - Hutchinson; Alan J. ; et al.	2006-01-12
Methods of treating cancer using C-4 carbonate taxanes App 20050250844 - Kadow, John F. ; et al.	2005-11-10
Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues App 20050239791 - Hutchison, Alan J. ; et al.	2005-10-27
C-5 Modified indazolylpyrrolotriazines App 20050209235 - Mastalerz, Harold ; et al.	2005-09-22
Process for the preparation of C-4 carbonate taxanes Grant 6,916,942 - Kadow , et al. July 12, 2	2005-07-12
C-5 modified indazolylpyrrolotriazines Grant 6,908,916 - Mastalerz , et al. June 21, 2	2005-06-21
Process for the preparation of C-4 carbonate taxanes App 20040225009 - Kadow, John F. ; et al.	2004-11-11
C-4 carbonate taxanes Grant 6,750,246 - Kadow , et al. June 15, 2	2004-06-15
Novel tyrosine kinase inhibitors App 20040044203 - Wittman, Mark D. ; et al.	2004-03-04
C-5 Modified indazolylpyrrolotriazines App 20030186983 - Mastalerz, Harold ; et al.	2003-10-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.